Range expansion and the origin of USA300 North American Epidemic Methicillin-Resistant Staphylococcus aureus
Cargando...
Fecha
2018
Título de la revista
Publicado en
mBio, 2150-7511, Vol. 9, Nro. 1, 2018 p. 1-15
Publicado por
American Society for Microbiology
URL de la fuente
Enlace a contenidos multimedia
ISSN de la revista
Título del volumen
Resumen
Descripción
Abstract
The USA300 North American epidemic (USA300-NAE) clone of methicillinresistant Staphylococcus aureus has caused a wave of severe skin and soft tissue infections in the United States since it emerged in the early 2000s, but its geographic
origin is obscure. Here we use the population genomic signatures expected from
the serial founder effects of a geographic range expansion to infer the origin of
USA300-NAE and identify polymorphisms associated with its spread. Genome sequences from 357 isolates from 22 U.S. states and territories and seven other countries are compared. We observe two significant signatures of range expansion, including decreases in genetic diversity and increases in derived allele frequency with
geographic distance from the Pennsylvania region. These signatures account for approximately half of the core nucleotide variation of this clone, occur genome wide,
and are robust to heterogeneity in temporal sampling of isolates, human population
density, and recombination detection methods. The potential for positive selection
of a gyrA fluoroquinolone resistance allele and several intergenic regions, along with
a 2.4 times higher recombination rate in a resistant subclade, is noted. These results are the first to show a pattern of genetic variation that is consistent with a range
expansion of an epidemic bacterial clone, and they highlight a rarely considered but
potentially common mechanism by which genetic drift may profoundly influence
bacterial genetic variation.
Palabras clave
Keywords
Epidemics, Fluoroquinolones, Founder effects
Temáticas
Genética
Variación genética
Staphylococcus aureus resistente a meticilina
Epidemiología
Variación genética
Staphylococcus aureus resistente a meticilina
Epidemiología